This study is testing the AIDANET system, an automated insulin delivery system, in children aged 6 to 13 years old with Type 1 Diabetes. The AIDANET system uses a smartphone-based control, a modified Tandem insulin pump, and a Dexcom G6 continuous glucose monitor (CGM). Researchers want to see if two different settings of the AIDANET system – a Normal Glycemia Goal and a Tight Glycemia Goal – are as good as usual care in managing blood sugar levels. You could be eligible if you are between 6 and 13 years old, have had Type 1 Diabetes for at least one year, and have been using an insulin pump for at least three months and insulin for at least six months. The study plans to enroll 42 participants, and its current status is unclear.

Study design

This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 42 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at 28 days, which suggests a follow-up period of at least this length.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.